SARS-CoV-2 infection and ACE2 inhibition
- PMID: 34188002
- DOI: 10.1097/HJH.0000000000002859
SARS-CoV-2 infection and ACE2 inhibition
Comment on
-
The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation.J Hypertens. 2021 Aug 1;39(8):1705-1716. doi: 10.1097/HJH.0000000000002829. J Hypertens. 2021. PMID: 34188005
References
-
- Centers for Disease Control and Prevention. 2019 novel coronavirus, Wuhan, China. Information for healthcare professionals. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html [Accessed 28 February 2021].
-
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–273.
-
- World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of the 31 December 2003). http://www.who.int/csr/sars/country/table2004_04_21/en/index.html [Accessed 28 February 2021].
-
- Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis 2020; 20:e238–e244.
-
- Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367:1260–1263.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous